1216488-91-3 Usage
Uses
Used in Pharmaceutical Industry:
[2-(4-Bromo-phenyl)-6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl]-methanol is used as a potential pharmaceutical compound for its unique structural features. The presence of the bromo-phenyl and trifluoromethyl groups may contribute to its binding affinity and selectivity towards specific biological targets, such as enzymes or receptors. This could make it a candidate for the development of new drugs targeting various diseases.
Used in Chemical Research:
In the field of chemical research, [2-(4-Bromo-phenyl)-6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl]-methanol serves as a subject for studying the effects of different functional groups on the compound's properties. Its synthesis and modification can provide insights into structure-activity relationships, potentially leading to the discovery of new chemical entities with improved or novel functionalities.
Used in Material Science:
[2-(4-Bromo-phenyl)-6-trifluoromethyl-imidazo[1,2-a]pyridin-3-yl]-methanol's unique structure may also find applications in material science, where its properties could be harnessed for the development of new materials with specific characteristics. For example, its potential use in the creation of advanced coatings, sensors, or other specialized materials could be explored based on its chemical and physical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 1216488-91-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,1,6,4,8 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1216488-91:
(9*1)+(8*2)+(7*1)+(6*6)+(5*4)+(4*8)+(3*8)+(2*9)+(1*1)=163
163 % 10 = 3
So 1216488-91-3 is a valid CAS Registry Number.
1216488-91-3Relevant academic research and scientific papers
IMIDAZOPYRIDINE COMPOUNDS
-
Page/Page column 41, (2010/06/20)
The invention relates to compounds of formula (I): and their pharmaceutically acceptable salts and solvates, which are inhibitors of SSAO activity. The invention further relates to pharmaceutical compositions comprising these compounds and to the use of these compounds for the treatment or prevention of medical conditions wherein inhibition of SSAO activity is beneficial, such as inflammatory diseases and immune disorders.
